查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1356773

血漿分餾冷鏈產品市場報告：2030 年趨勢、預測與競爭分析

Cold Chain Products for Plasma Fractionation Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

血漿分餾冷鏈產品的趨勢與預測

到 2030 年，全球血漿分餾冷鏈產品市場預計將達到 7 億美元，2024 年至 2030 年年複合成長率為 4.6%。該市場的主要促進因素是免疫球蛋白和其他血漿產品的使用不斷增加、治療慢性疾病的血漿藥物需求不斷成長以及冷凍設備和系統的不斷進步。全球血漿分餾冷鏈產品市場前景廣闊，採血中心和血液成分供應商、醫院和輸血中心以及臨床研究實驗室市場存在商機。

血漿分餾冷鏈產品市場洞察

Lucintel 預測，溫度監控設備將在預測期內達到最高成長。

由於免疫不全症病、肝病和高齡化疾病的增加，預計血液採集中心和血液成分供應商仍將是最大的細分市場。

由於對等離子冷凍庫的需求不斷增加以及該地區實驗室先進的冷藏設備的可用性，預計北美在預測期內仍將是最大的市場。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要要素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些，由於材料或產品替代導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 血漿分餾冷鏈產品的全球市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 血漿分餾冷鏈產品的全球市場趨勢（2018-2023）與預測（2024-2030）
  • 按類型分類的血漿分餾冷鏈產品的全球市場
    • 超低溫冷凍庫
    • 血漿冷凍庫
    • 溫度監控裝置
    • 用於血漿的接觸式衝擊冷凍機
    • 血液運輸箱
    • 內襯冰的冰箱
    • 其他
  • 以最終用途分類的血漿分餾冷鏈產品的全球市場
    • 採血中心/血液成分提供者
    • 醫院/輸血中心
    • CRO
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球血漿分餾冷鏈產品市場（按地區）
  • 北美血漿分餾冷鏈產品市場
  • 歐洲血漿分餾冷鏈產品市場
  • 亞太地區血漿分餾冷鏈產品市場
  • 其他地區血漿分餾冷鏈產品市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按類型分類的血漿分餾冷鏈產品的全球市場成長機會
    • 按最終用途的血漿分餾冷鏈產品的全球市場成長機會
    • 按地區血漿分餾冷鏈產品的全球市場成長機會
  • 全球血漿分餾冷鏈產品市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大血漿分餾冷鏈產品的全球市場容量
    • 全球血漿分餾冷鏈產品市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • B Medical systems
  • Blue Star
  • Thermo Fisher Scientific
  • Godrej and Boyce
  • Haier Biomedical
  • Eppendorf
  • Avantor
  • Biolife Solutions
簡介目錄

Cold Chain Products For Plasma Fractionation Trends and Forecast

The future of the global cold chain products market for plasma fractionation looks promising with opportunities in the blood collection center and blood component provider, hospital and transfusion center, and clinical research laboratorie markets. The global cold chain products market for plasma fractionation is expected to reach an estimated $700 million by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are increasing use of immunoglobulins and other plasma products, growing need for plasma-based medicines to treat chronic conditions, and on-going advancement in refrigeration equipment and systems.

A more than 150-page report is developed to help in your business decisions.

Cold Chain Products For Plasma Fractionation by Segment

The study includes a forecast for the global cold chain products for plasma fractionation by type, end use, and region.

Cold Chain Products Market for Plasma Fractionation by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Ultra-low temperature freezer
  • Plasma freezer
  • Temperature monitoring devices
  • Plasma contact shock freezer
  • Blood transport boxes
  • Ice-lined refrigerator
  • Others

Cold Chain Products Market for Plasma Fractionation by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Blood collection centers and blood component providers
  • Hospitals and transfusion centers
  • Clinical research laboratories
  • Others

Cold Chain Products Market for Plasma Fractionation by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cold Chain Products Companies for Plasma Fractionation

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cold chain products companies for plasma fractionation cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cold chain products for plasma fractionation companies profiled in this report include-

  • B Medical Systems
  • Blue Star
  • Thermo Fisher Scientific
  • Godrej And Boyce
  • Haier Biomedical
  • Eppendorf
  • Avantor
  • Biolife Solutions

Cold Chain Products for Plasma Fractionation Market Insights

Lucintel forecasts that temperature monitoring device is expected to witness highest growth over the forecast period.

Blood collection center and blood component provider will remain the largest segment due to increasing number of diseases like hemophilia and immune deficiency disorders as well as liver diseases and rising aging population.

North America will remain the largest segment over the forecast period due to increasing demand of plasma freezer demand and availability of advanced cold storage equipment for laboratories in the region.

Features of the Global Cold Chain Products Market for Plasma Fractionation

Market Size Estimates: Cold chain products market for plasma fractionation size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cold chain products market for plasma fractionation size by type, end use, and region. in terms of value ($M).

Regional Analysis: Cold chain products market for plasma fractionation breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and region.s for the cold chain products market for plasma fractionation.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cold chain products market for plasma fractionation.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the cold chain products market for plasma fractionation size?

Answer: The global cold chain products market for plasma fractionation is expected to reach an estimated $700 million by 2030.

Q.2. What is the growth forecast for cold chain products market for plasma fractionation?

Answer: The global cold chain products market for plasma fractionation is expected to grow with a CAGR of 4.6% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the cold chain products market for plasma fractionation?

Answer: The major drivers for this market are increasing use of immunoglobulins and other plasma products, growing need for plasma-based medicines to treat chronic conditions, and on-going advancement in refrigeration equipment and systems.

Q.4. What are the major segments for cold chain products market for plasma fractionation?

Answer: The future of the global cold chain products market for plasma fractionation looks promising with opportunities in the blood collection center and blood component provider, hospital and transfusion center, and clinical research laboratorie markets.

Q.5. Who are the key cold chain products market for plasma fractionation companies?

Answer: Some of the key cold chain products for plasma fractionation companies are as follows:

  • B Medical systems
  • Blue Star
  • Thermo Fisher Scientific
  • Godrej and Boyce
  • Haier Biomedical
  • Eppendorf
  • Avantor
  • Biolife Solutions

Q.6. Which cold chain products market for plasma fractionation segment will be the largest in future?

Answer: Lucintel forecasts that temperature monitoring device is expected to witness highest growth over the forecast period.

Q.7. In cold chain products market for plasma fractionation, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to increasing demand of plasma freezer demand and availability of advanced cold storage equipment for laboratories in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cold chain products market for plasma fractionation by type (ultra-low temperature freezer, plasma freezer, temperature monitoring devices,plasma contact shock freezer, blood transport boxes, ice-lined refrigerator, and others), end use (blood collection centers and blood component providers, hospitals and transfusion centers, clinical research laboratories, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cold Chain Products Market for Plasma Fractionation: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cold Chain Products Market for Plasma Fractionation Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cold Chain Products Market for Plasma Fractionation by Type
    • 3.3.1: Ultra-low Temperature Freezer
    • 3.3.2: Plasma Freezer
    • 3.3.3: Temperature Monitoring Devices
    • 3.3.4: Plasma Contact Shock Freezer
    • 3.3.5: Blood Transport Boxes
    • 3.3.6: Ice-lined Refrigerator
    • 3.3.7: Others
  • 3.4: Global Cold Chain Products Market for Plasma Fractionation by End Use
    • 3.4.1: Blood collection Centers and Blood Component Providers
    • 3.4.2: Hospitals and Transfusion Centers
    • 3.4.3: Clinical Research Laboratories
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cold Chain Products Market for Plasma Fractionation by Region
  • 4.2: North American Cold Chain Products Market for Plasma Fractionation
    • 4.2.2: North American Cold Chain Products Market for Plasma Fractionation by End Use: Blood collection Centers and Blood Component Providers, Hospitals and Transfusion Centers, Clinical Research Laboratories, and Others
  • 4.3: European Cold Chain Products Market for Plasma Fractionation
    • 4.3.1: European Cold Chain Products Market for Plasma Fractionation by Type: Ultra-low temperature Freezer, Plasma Freezer, Temperature Monitoring Devices, Plasma Contact Shock Freezer, Blood Transport Boxes, Ice-lined Refrigerator, and Others
    • 4.3.2: European Cold Chain Products Market for Plasma Fractionation by End Use: Blood collection Centers and Blood Component Providers, Hospitals and Transfusion Centers, Clinical Research Laboratories, and Others
  • 4.4: APAC Cold Chain Products Market for Plasma Fractionation
    • 4.4.1: APAC Cold Chain Products Market for Plasma Fractionation by Type: Ultra-low temperature Freezer, Plasma Freezer, Temperature Monitoring Devices, Plasma Contact Shock Freezer, Blood Transport Boxes, Ice-lined Refrigerator, and Others
    • 4.4.2: APAC Cold Chain Products Market for Plasma Fractionation by End Use: Blood collection Centers and Blood Component Providers, Hospitals and Transfusion Centers, Clinical Research Laboratories, and Others
  • 4.5: ROW Cold Chain Products Market for Plasma Fractionation
    • 4.5.1: ROW Cold Chain Products Market for Plasma Fractionation by Type: Ultra-low temperature Freezer, Plasma Freezer, Temperature Monitoring Devices, Plasma Contact Shock Freezer, Blood Transport Boxes, Ice-lined Refrigerator, and Others
    • 4.5.2: ROW Cold Chain Products Market for Plasma Fractionation by End Use: Blood collection Centers and Blood Component Providers, Hospitals and Transfusion Centers, Clinical Research Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cold Chain Products Market for Plasma Fractionation by Type
    • 6.1.2: Growth Opportunities for the Global Cold Chain Products Market for Plasma Fractionation by End Use
    • 6.1.3: Growth Opportunities for the Global Cold Chain Products Market for Plasma Fractionation by Region
  • 6.2: Emerging Trends in the Global Cold Chain Products Market for Plasma Fractionation
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cold Chain Products Market for Plasma Fractionation
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cold Chain Products Market for Plasma Fractionation
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: B Medical systems
  • 7.2: Blue Star
  • 7.3: Thermo Fisher Scientific
  • 7.4: Godrej and Boyce
  • 7.5: Haier Biomedical
  • 7.6: Eppendorf
  • 7.7: Avantor
  • 7.8: Biolife Solutions